Bayer and Evotec Collaborate to Advance Precision Cardiology

BAYER AND EVOTEC UPDATE FOCUS OF THEIR COLLABORATION TO CARDIOVASCULAR DISEASESSTRATEGIC ALLIANCE LEVERAGES HUMAN INDUCED PLURIPOTENT STEM CELL DISEASE MODELLING FOR IDENTIFICATION OF NOVEL TARGETSJOI

AccesswireApr 30 14:50

Evotec SE (ETR:EVT) Yearly Results: Here's What Analysts Are Forecasting For This Year

Yahoo FinanceApr 26 14:29

Evotec Is Maintained at Buy by HC Wainwright & Co.

Evotec Is Maintained at Buy by HC Wainwright & Co.

Dow JonesApr 25 19:15

Evotec Price Target Cut to $11.00/Share From $14.00 by HC Wainwright & Co.

Evotec Price Target Cut to $11.00/Share From $14.00 by HC Wainwright & Co.

Dow JonesApr 25 19:15

HC Wainwright & Co. Maintains Buy on Evotec, Lowers Price Target to $11

HC Wainwright & Co. analyst Douglas Tsao maintains Evotec with a Buy and lowers the price target from $14 to $11.

Analyst UpgradesApr 25 19:07

Evotec Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/25/2024 114.84% HC Wainwright & Co. $14 → $11 Maintains Buy 08/31/2023 173.44% HC Wainwright & Co. $12

BenzingaApr 25 19:03